vTv Therapeutics Inc.
VTVT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | -49.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | – | 100% | 100% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -2,214% | – | -1,227.3% | -437.3% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,815.3% | – | -949.7% | -324.3% |
| EPS Diluted | -3.2 | -9.71 | -9.98 | -8.29 |
| % Growth | 67% | 2.7% | -20.4% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | -$0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |